CaMK2 alpha Recombinant Antibody

$25 ug total protein per lane of various lysates (see on figure) probed with CaMK2 alpha monoclonal antibody, unconjugated (bsm-61318R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.$

25 ug total protein per lane of various lysates (see on figure) probed with CaMK2 alpha monoclonal antibody, unconjugated (bsm-61318R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.

Applications

Reactivity

Human
Mouse
Rat

Overview
Catalog #	bsm-61318r-100ul
Product Name	CaMK2 alpha Recombinant Antibody
Applications	WB, FCM, IP
Reactivity	Human, Mouse, Rat
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human CaMKII alpha
Clonality	Recombinant
Isotype	IgG
Concentration	Lot dependent
Purification	Purified by Protein A.
Storage Buffer	10mM phosphate buffered saline(pH 7.4) with 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.
Storage Condition	Shipped at 4°. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	815
Swiss Prot	Q9UQM7
Subcellular location	Cell membrane
Synonyms	Alpha CaMKII; Camk2a; CAMKA; CaMKII; CaMKIINalpha; PK2CDD; PKCCD.
Background	Calcium/calmodulin-dependent protein kinase that functions autonomously after Ca2+/calmodulin-binding and autophosphorylation, and is involved in various processes, such as synaptic plasticity, neurotransmitter release and long-term potentiation.Member of the NMDAR signaling complex in excitatory synapses, it regulates NMDAR-dependent potentiation of the AMPAR and therefore excitatory synaptic transmission.
Application Dilution
WB	1:300-5000
FCM	1:20-100
IP	1-2ug